Results 71 to 80 of about 15,137 (114)

State of the Art on Thyroid Cancer Biology and Oncology. [PDF]

Biomedicines
Vaio F, Moliterni C, Mardente S, Misasi R, Mari E.   +4 more
europepmc   +1 more source

Inhibitory Effects of Vandetanib on Catecholamine Synthesis in Rat Pheochromocytoma PC12 Cells. [PDF]

Int J Mol Sci
Itoh Y, Inagaki K, Terasaka T, Morimoto E, Ishii T, Yamaoka K, Fujisawa S, Wada J.   +7 more
europepmc   +1 more source

<i>RET</i> Gene Alterations in Clinical Practice: A Comprehensive Review and Database Update. [PDF]

Genes (Basel)
Ricciardi Tenore C, Tulli E, Perrucci A, Bertozzi R, Fortuna L, Maneri G, Santonocito C, Urbani A, De Bonis M, Minucci A.   +9 more
europepmc   +1 more source

Expression von Oberflächenrezeptoren beim Bronchialkarziom [PDF]

, 1999
PD Dr. Schuermann, Wimmel, Anja
core   +1 more source

Preoperative selpercatinib induces major pathological response in a patient with stage IIIA, RET fusion-positive non-small cell lung cancer: A case report. [PDF]

Medicine (Baltimore)
Breitenecker K, Fabikan H, Weinlinger C, Krenbek D, Klikovits T, Watzka S, Valipour A, Hochmair MJ.   +7 more
europepmc   +1 more source

Advances in Tissue-Agnostic Targeting in Cancer Therapeutics: Current Approvals, Challenges, and Future Directions. [PDF]

Oncol Res
Rubinstein M, Hong ML, Nanda RK, Jones DT, Aboaid H, Myat YM, Thein KZ.   +6 more
europepmc   +1 more source

Molecular Alterations and Pathways in Intrahepatic Cholangiocarcinoma: Available Evidence and New Perspectives. [PDF]

Int J Mol Sci
Astore M, Fabbri L, Monte A, Deiana C, Rizzo A, Tavolari S, Deserti M, Brandi G, Palloni A, Frega G.   +9 more
europepmc   +1 more source

Genotype-phenotype correlations of germline mutations in exon 10 of the RET proto-oncogene from 14 MEN2A families of Ethnic Han Chinese. [PDF]

PLoS One
Li F, Chen W, Chen Z, Lian B, Fang X, Jin H, Wang H, Zhao J, Zhang Y, Qi X.   +9 more
europepmc   +1 more source

Advances in Targeted Therapy for Non-Small-Cell Lung Cancer: Current Progress and Future Directions. [PDF]

Int J Mol Sci
Peshin S, Takrori E, Yazji JH, Haque J, Dharia A, Mithani MS, Anum F, Asfeen U, Couch JK, Donovan M, Singal S.   +10 more
europepmc   +1 more source

Successful treatment with sintilimab plus anlotinib for SMARCA4-deficient non-small cell lung cancer withMET exon 14 skipping: a case report. [PDF]

Nagoya J Med Sci
Zhao H, Zhang C, Chen D, Ye W, Shi Q.
europepmc   +1 more source